2008
Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection Among Young Drug-users In New York City
Amesty S, Ompad D, Galea S, Fuller C, Wu Y, Koblin B, Vlahov D. Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection Among Young Drug-users In New York City. Journal Of Community Health 2008, 33: 139-148. PMID: 18185987, DOI: 10.1007/s10900-007-9082-4.Peer-Reviewed Original ResearchConceptsEvidence of infectionHBV vaccinationPrevious vaccinationSerological evidenceHepatitis B vaccination coveragePrevious hepatitis B vaccinationPrevious HBV infectionPrevious HBV vaccinationHepatitis B vaccinationHepatitis B vaccineHigh-risk groupYears of ageCommunity-based sampleB vaccinationHBV infectionB vaccineVaccination statusVaccination coverageRisk groupsHigh school educationVaccinationSusceptible individualsDrug usersInfection rateBivariate analysis
2003
The Role of Medicaid HMO Enrollment in the Longitudinal Utilization of Medical Care Services in a Cohort of Injecting Drug users in Baltimore, Maryland
Juday T, Wu A, Celentano D, Rick K, Wang M, Vlahov D. The Role of Medicaid HMO Enrollment in the Longitudinal Utilization of Medical Care Services in a Cohort of Injecting Drug users in Baltimore, Maryland. Substance Use & Addiction Journal 2003, 24: 27-41. PMID: 12652093, DOI: 10.1080/08897070309511531.Peer-Reviewed Original ResearchConceptsAmbulatory care visitsCare visitsInpatient admissionsHMO enrollmentDrug usersMedicaid HMO enrolleesMore inpatient admissionsInjecting Drug UsersMedical care utilizationNatural history studiesIntravenous Experience (ALIVE) studyMedical care servicesCommunity-based sampleLongitudinal utilizationER visitsHIV infectionCare utilizationMedicaid beneficiariesHMO enrolleesCare servicesIDUsInappropriate utilizationUtilization differencesMedicaidMedicaid HMOs
1992
Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading?
ALCABES P, VLAHOV D, ANTHONY J. Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading? Addiction 1992, 87: 47-54. PMID: 1311973, DOI: 10.1111/j.1360-0443.1992.tb01899.x.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHIV-1 seropositivityDrug usersTreatment programHuman immunodeficiency virus (HIV) infectionHIV-1 seroprevalenceImmunodeficiency virus infectionHuman immunodeficiency virusDrug use characteristicsCommunity-based sampleDrug use behaviorsImmunodeficiency virusPossible selection biasRisk factorsVirus infectionType 1SeropositivityTreatmentCommunity service agenciesConfidential interviewsSelection biasSubjectsUse behaviorsExtensive distributionCorrelates